A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Clinical trial NCT06782373 · RECRUITING
Trial details
- NCT number
- NCT06782373
- Sponsor
- Swedish Orphan Biovitrum
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-28
- Primary completion
- 2026-12-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.